| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2020 | IQV Iqvia Holdings Inc. | Bousbib Ari64 | See Remarks | Sell | 69,120 | $161.66 | $11,173,939.20 | -9.6% | |
| Aug 13, 2020 | PRPH Prophase Labs, Inc. | Gleckel Louis Md | - | Buy | 50,000 | $2.75 | $137,500.00 | +22.3% | |
| Aug 13, 2020 | PRPH Prophase Labs, Inc. | Karkus Ted William | CEO &Chairman | Sell | 50,000 | $2.75 | $137,500.00 | -2.0% | |
| Aug 13, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 38,587 | $127.50 | $4,919,655.13 | -0.3% | |
| Aug 13, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 13,500 | $41.23 | $556,582.10 | -0.2% | |
| Aug 13, 2020 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Chairman Of The Bd. | Sell | 2,075 | $967.88 | $2,008,352.79 | -10.1% | |
| Aug 13, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 38,587 | $127.50 | $4,919,655.13 | -0.3% | |
| Aug 11, 2020 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,396 | $42.06 | $58,711.71 | -0.3% | |
| Aug 11, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 86,790 | $122.80 | $10,657,639.52 | -0.6% | |
| Aug 11, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 86,790 | $122.80 | $10,657,639.52 | -0.6% | |
| Aug 10, 2020 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director | Sell | 25,000 | $42.01 | $1,050,305.00 | -2.2% | |
| Aug 10, 2020 | MEDP Medpace Holdings, Inc. | Ewald Stephen P59 | General Counsel &Corp. Secy. | Sell | 7,400 | $121.57 | $899,618.00 | -68.9% | |
| Aug 10, 2020 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 5,000 | $87.00 | $435,000.00 | -55.2% | |
| Aug 7, 2020 | MTD Mettler Toledo International Inc/ | Salice Thomas P65 | Director | Sell | 4,000 | $941.52 | $3,766,065.76 | -3.2% | |
| Aug 7, 2020 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 3,304 | $216.54 | $715,443.83 | -7.2% | |
| Aug 7, 2020 | CRL Charles River Laboratories International, Inc. | Kochevar Deborah Turner | Director | Sell | 2,319 | $216.24 | $501,466.82 | -25.6% | |
| Aug 7, 2020 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 3,456 | $216.60 | $748,555.50 | -38.8% | |
| Aug 7, 2020 | IQV Iqvia Holdings Inc. | Staub W Richard | See Remarks | Sell | 20,367 | $160.32 | $3,265,332.37 | -34.6% | |
| Aug 7, 2020 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs. | Sell | 9,503 | $934.55 | $8,881,028.70 | -3.0% | |
| Aug 7, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,500 | $41.47 | $311,005.85 | -0.3% | |
| Aug 7, 2020 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 34,975 | $123.11 | $4,305,919.65 | -0.2% | |
| Aug 7, 2020 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 34,975 | $123.11 | $4,305,919.65 | -0.2% | |
| Aug 7, 2020 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 24,000 | $217.49 | $5,219,771.27 | -5.2% | |
| Aug 6, 2020 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 7,000 | $126.00 | $882,000.00 | -15.2% | |
| Aug 6, 2020 | NEO Neogenomics Inc | Cardoza George | President, Pharma Services | Sell | 82,500 | $39.35 | $3,246,375.00 | -19.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.